Evidence map›Paper›PMID 41094304›Full record

ArticleJournal of cancer research and clinical oncology2025

Comment on: Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma.

Doga Topkan, Efsun Somay, Erkan Topkan, Ugur Selek

Abstract readLetter
In one paragraph

Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Doga TopkanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.ORCID http://orcid.org/0009-0004-9399-7846
Efsun SomayDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 82. Street No: 26, Bahcelievler, Ankara, Turkey. efsuner@gmail.com.ORCID http://orcid.org/0000-0001-8251-6913
Erkan TopkanDepartment of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.ORCID http://orcid.org/0000-0001-8120-7123
Ugur SelekDepartment of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-8087-3140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Borowczak et al. recently explored the prognostic role of heat shock proteins HSP27 and HSP70 in laryngeal squamous cell carcinoma (LSCC). Their study demonstrated that lower expression levels of these proteins were linked to significantly reduced overall survival, suggesting potential utility as prognostic biomarkers in this patient population. This work adds important evidence to the limited pool of molecular predictors available for LSCC. However, paradoxical findings, such as the survival advantage observed with higher HSP expression despite their well-known cytoprotective roles, raise questions regarding underlying mechanisms. Factors such as subcellular localization, treatment intensity, and environmental exposures like alcohol consumption may influence these associations. Consequently, further translational research is needed to validate the prognostic significance of HSP27 and HSP70 and to clarify their clinical applicability in LSCC management.

Indexed as

Carcinoma, Squamous CellHSP27 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsLaryngeal NeoplasmsBiomarkers, TumorHeat-Shock ProteinsHumansMolecular ChaperonesPrognosisBiomarkers, TumorHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSPB1 protein, humanMolecular ChaperonesAlcohol consumptionHeat shock proteinsHSP27HSP70Laryngeal squamous cell carcinomaPrognostic biomarkersSubcellular localization

Identifiers

PMID41094304
PMCPMC12528586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.